Impact of Pandemic Mitigation Efforts on Colonization and Transmission of Respiratory Pathogens and Antibiotic Resistance Genes

流行病缓解措施对呼吸道病原体和抗生素抗性基因定植和传播的影响

基本信息

  • 批准号:
    10641008
  • 负责人:
  • 金额:
    $ 21.63万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2022
  • 资助国家:
    美国
  • 起止时间:
    2022-06-08 至 2024-05-31
  • 项目状态:
    已结题

项目摘要

ABSTRACT Nasopharyngeal (NP) colonization with commensal and pathogenic organisms is common and a dynamic process. While these dynamics typically occur in the healthy state, many respiratory viruses and colonizing bacteria are important causes of acute respiratory illness (ARI) and invasive disease. Respiratory viruses and bacteria also exhibit interactions that are important in ARI pathogenesis. The initial period shortly after acquisition of respiratory bacteria or infection with respiratory viruses is particularly critical, imparting an increase in ARI risk. S. pneumoniae, S. aureus, and other colonizing bacteria also commonly express antibiotic resistance genes that may be transferred or exchanged between co-colonizing organisms. Broad mitigation strategies were implemented for SARS-CoV-2 pandemic control in many settings, including use of face coverings, stay-at-home orders, and school closures. Collectively, these efforts were associated with reduced community transmission of SARS-CoV-2. In addition, ecologic studies during these periods also demonstrated interruptions in influenza, respiratory syncytial virus, and S. pneumoniae disease activity that were very substantial, dwarfing the success of existing preventive strategies, including vaccines, which are available against only few respiratory pathogens and limited in their scope and effectiveness. Understanding the impact of mitigation strategies on the activity of colonizing respiratory pathogens beyond SARS-CoV-2 would inform efforts to understand infection dynamics and reduce the burden of these common yet currently unpreventable infections. We conducted intensive household-based ARI surveillance in Lima, Peru during the same period in two consecutive years: 2019, just prior to the COVID-19 pandemic, and 2020, during peak SARS-CoV-2 activity. We aim to leverage this unique platform to characterize patterns of household acquisition and infection with respiratory pathogens during periods with and without mitigation strategies through the conduct of two Specific Aims: 1) To test the hypothesis that mitigation strategies are associated with a) fewer acquisitions of colonizing respiratory bacteria, b) fewer infections with respiratory viruses, shorter durations of colonization/detections, and reduced transmission of these pathogens among children and adults in households in semi-urban Peru, and 2) To test the hypothesis that mitigation strategies are associated with fewer acquisitions, shorter duration of detection, and reduced household transmission of nasopharyngeal antibiotic resistance genes among children and adults in households in semi-urban Peru. A detailed understanding of the impact of these mitigation strategies on the dynamics of colonization with clinically relevant respiratory pathogens may inform targeted applications to reduce the global impact of ARI and pneumonia, particularly for infections that are not yet vaccine-preventable.
抽象的 具有共生和致病生物的鼻咽(NP)定植是常见的,A 动态过程。尽管这些动态通常发生在健康状态,但许多呼吸道病毒和 定植细菌是急性呼吸系统疾病(ARI)和侵入性疾病的重要原因。呼吸道 病毒和细菌还表现出在ARI发病机理中很重要的相互作用。最初的时间很快 在获取呼吸道细菌或用呼吸道病毒感染后,特别关键 ARI风险增加。肺炎链球菌,金黄色葡萄球菌和其他定植细菌也通常表达抗生素 可以在共殖化生物之间转移或交换的抗性基因。 在许多情况下,针对SARS-COV-2大流行控制实施了广泛的缓解策略, 包括使用面部覆盖物,全职订单和学校关闭。总的来说,这些努力是 与SARS-COV-2的社区传播减少有关。此外,在这些过程中 时期还表明流感,呼吸道合胞病毒和肺炎链球菌的中断 活动非常实质,使​​现有预防策略的成功相形见var,包括疫苗, 仅与少数呼吸道病原体可用,并且其范围和有效性有限。 了解缓解策略对殖民呼吸道病原体活动的影响 SARS-COV-2将为理解感染动态的努力提供信息,并减轻这些常见的负担 目前目前无法预防的感染。 我们在同一时期在秘鲁利马进行了密集的家庭ARI监视 连续几年:2019年,在COVID-19-19大流行之前和2020年,在SARS-COV-2活性期间。 我们旨在利用这个独特的平台来表征家庭获取和感染模式 通过进行两种特定的特定时期,在有或没有缓解策略的期间呼吸道病原体 目的:1)检验缓解策略与a)殖民殖民较少相关的假设 呼吸道细菌,b)呼吸道病毒感染较少,定殖/检测持续时间较短, 并减少了这些病原体在秘鲁半城市的家庭中的儿童和成人中的传播, 2)测试缓解策略与较少的获取相关的假设,持续时间较短 检测和鼻咽抗生素抗性基因的家庭传播减少 秘鲁半城市家庭的儿童和成人。对这些影响的详细理解 与临床相关的呼吸道病原体有关殖民动力学动态的缓解策略可能会告知 有针对性的应用程序来减少ARI和肺炎的全球影响,特别是对于不是 但可预防疫苗。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

CARLOS G GRIJALVA其他文献

CARLOS G GRIJALVA的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('CARLOS G GRIJALVA', 18)}}的其他基金

Peru Vanderbilt – PREvention through VacciNation Training (PREVENT) program
秘鲁范德比尔特 — 通过疫苗接种培训进行预防 (PREVENT) 计划
  • 批准号:
    10674393
  • 财政年份:
    2023
  • 资助金额:
    $ 21.63万
  • 项目类别:
Human rhinovirus infection and susceptibility to SARS-CoV-2 infection and symptomatic disease
人类鼻病毒感染以及对 SARS-CoV-2 感染和症状性疾病的易感性
  • 批准号:
    10726391
  • 财政年份:
    2023
  • 资助金额:
    $ 21.63万
  • 项目类别:
Impact of Pandemic Mitigation Efforts on Colonization and Transmission of Respiratory Pathogens and Antibiotic Resistance Genes
流行病缓解措施对呼吸道病原体和抗生素抗性基因定植和传播的影响
  • 批准号:
    10510137
  • 财政年份:
    2022
  • 资助金额:
    $ 21.63万
  • 项目类别:
Gestational diabetes drugs and perinatal outcomes in underserved populations
妊娠糖尿病药物和服务不足人群的围产期结局
  • 批准号:
    10487395
  • 财政年份:
    2021
  • 资助金额:
    $ 21.63万
  • 项目类别:
Gestational diabetes drugs and perinatal outcomes in underserved populations
妊娠糖尿病药物和服务不足人群的围产期结局
  • 批准号:
    10193041
  • 财政年份:
    2021
  • 资助金额:
    $ 21.63万
  • 项目类别:
Mentoring in transmission of influenza and strategies for prevention
流感传播的指导和预防策略
  • 批准号:
    10555283
  • 财政年份:
    2020
  • 资助金额:
    $ 21.63万
  • 项目类别:
Mentoring in transmission of influenza and strategies for prevention
流感传播的指导和预防策略
  • 批准号:
    10356800
  • 财政年份:
    2020
  • 资助金额:
    $ 21.63万
  • 项目类别:
Mentoring in transmission of influenza and strategies for prevention
流感传播的指导和预防策略
  • 批准号:
    10094190
  • 财政年份:
    2020
  • 资助金额:
    $ 21.63万
  • 项目类别:
Learning Health System training program: PROgRESS--Patient/ pRactice Outcomes and Research in Effectiveness and Systems Science
学习健康系统培训计划:PROgRESS--患者/实践成果以及有效性和系统科学的研究
  • 批准号:
    10425309
  • 财政年份:
    2018
  • 资助金额:
    $ 21.63万
  • 项目类别:
Learning Health System training program: PROgRESS--Patient/ pRactice Outcomes and Research in Effectiveness and Systems Science
学习健康系统培训计划:PROgRESS--患者/实践成果以及有效性和系统科学的研究
  • 批准号:
    10192698
  • 财政年份:
    2018
  • 资助金额:
    $ 21.63万
  • 项目类别:

相似国自然基金

阿魏酸基天然抗氧化抗炎纳米药物用于急性肾损伤诊疗一体化研究
  • 批准号:
    82302281
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
SGO2/MAD2互作调控肝祖细胞的细胞周期再进入影响急性肝衰竭肝再生的机制研究
  • 批准号:
    82300697
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
基于hemin-MOFs的急性心肌梗塞标志物负背景光电化学-比色双模分析
  • 批准号:
    22304039
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
RNA甲基转移酶NSUN2介导SCD1 mRNA m5C修饰调控急性髓系白血病细胞铁死亡的机制研究
  • 批准号:
    82300173
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
基于IRF5/MYD88信号通路调控巨噬细胞M1极化探讨针刀刺营治疗急性扁桃体炎的机制研究
  • 批准号:
    82360957
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    地区科学基金项目

相似海外基金

Mentoring Emerging Researchers at CHLA (MERCH-LA)
指导 CHLA (MERCH-LA) 的新兴研究人员
  • 批准号:
    10797938
  • 财政年份:
    2023
  • 资助金额:
    $ 21.63万
  • 项目类别:
Establishment of a Bat Resource for Infectious Disease Research
建立用于传染病研究的蝙蝠资源
  • 批准号:
    10495114
  • 财政年份:
    2023
  • 资助金额:
    $ 21.63万
  • 项目类别:
Resources, Workforce Development, and Animal Models for the Rutgers RBL
罗格斯大学 RBL 的资源、劳动力发展和动物模型
  • 批准号:
    10793863
  • 财政年份:
    2023
  • 资助金额:
    $ 21.63万
  • 项目类别:
Potential role of skin in SARS-CoV-2 infection
皮肤在 SARS-CoV-2 感染中的潜在作用
  • 批准号:
    10593622
  • 财政年份:
    2023
  • 资助金额:
    $ 21.63万
  • 项目类别:
MLL1 drives collaborative leukocyte-endothelial cell signaling and thrombosis after coronavirus infection
MLL1在冠状病毒感染后驱动白细胞-内皮细胞信号传导和血栓形成
  • 批准号:
    10748433
  • 财政年份:
    2023
  • 资助金额:
    $ 21.63万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了